Weight Loss Drug
-
{
- All
- News
- Videos
- Web Stories
-
China's New Twice-Monthly GLP-1 Shot Helps With Weight Loss In Trails
Bofanglutide, a new biweekly drug, has demonstrated strong efficacy in reducing blood sugar in people with type 2 diabetes.
-
This Simple Blood Test Could Predict Which Weight-Loss Drug Will Work Best For You, Says Study
People with low GIP levels responded best to tirzepatide, regardless of their GLP-1 levels. On the other hand, those with low GLP-1 levels and medium to high GIP levels had the best response to semaglutide.
-
Considering Weight Loss Drugs? 7 Things You Should Know First
Using weight loss drugs is a personal decision that should be made based on informed discussions with healthcare providers and thorough research into the options available.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
America's Most Talked-About Drug Has A Surprising Secret: 69% of GLP-1 Users Are Unlikely To Admit Taking It
While GLP-1 medications have become one of the most visible health trends in America, a report found that less than a third (31%) of current and former GLP-1 users are likely to admit to using one.
-
Ozempic-Mounjaro Paved The Way: 3 New Drugs Likely To Enter Weight Loss Market
Ozempic and Mounjaro are popular weight loss medications that were developed for blood sugar control in individuals with diabetes. Here are the 3 new drugs that are likely to enter the weight loss market as oral GLP-1 drugs.
-
AstraZeneca's Oral GLP-1 Drug Elecoglipron Drives Up To 11.8% Weight Loss In Trial
The positive results come from the Phase 2 VISTA clinical trial, which evaluated elecoglipron in adults with obesity or overweight who also had at least one weight-related health condition.
-
Big Bang Theory's Mayim Bialik's GLP-1 Drug Experience Was A "Nightmare": What Happened
Bialik explained that she did not start taking a GLP-1 drug simply to lose weight. Instead, she hoped it might help with health issues that had affected her for years.
-
Weight Loss Drugs Reduce The Risk Of Breast Cancer By 30%, Finds New Study
Researchers examined health records to compare women who used GLP-1 medications with those who did not. The results showed that women taking these drugs were about 30% less likely to develop breast cancer than women who were not using them.
-
Harvard-Trained Gastroenterologist Reveals What Most People Miss About GLP-1 Drugs
Strap: A Harvard- and Stanford-trained gastroenterologist shares some key facts on GLP-1 drugs that most people often ignore.
-
Ozempic And Wegovy Weight Loss Eventually Plateaus, Study Explains Why
While semaglutide has shown impressive results in aiding weight loss, many users may experience a plateau after an initial period of significant weight loss.
-
Popular Weight Loss Drug Wegovy Linked To Rare Blinding Eye Condition, Finds Study
The study does not say that Wegovy directly causes blindness. Instead, researchers found a strong link between the drug and a condition called ischemic optic neuropathy.
-
Weight Loss Drugs May Impact Brain's Reward Centre, Study Warns
Newer oral weight loss drugs could be doing more than only suppressing appetite -- they may also be directly altering brain circuits that control motivation and reward, according to a new study.
-
Dr Reddy's Wins Nod to Sell Generic Ozempic, Check Cost Of Weight-Loss Drug
The entry of Dr Reddy's generic is triggering a price battle among pharmaceutical companies worldwide.
-
Fake Weight Loss Drug Racket Busted In Gurugram, 2 Arrested
Authorities arrest two in Gurugram for making and selling fake Mounjaro injections.
-
China's New Twice-Monthly GLP-1 Shot Helps With Weight Loss In Trails
Bofanglutide, a new biweekly drug, has demonstrated strong efficacy in reducing blood sugar in people with type 2 diabetes.
-
This Simple Blood Test Could Predict Which Weight-Loss Drug Will Work Best For You, Says Study
People with low GIP levels responded best to tirzepatide, regardless of their GLP-1 levels. On the other hand, those with low GLP-1 levels and medium to high GIP levels had the best response to semaglutide.
-
Considering Weight Loss Drugs? 7 Things You Should Know First
Using weight loss drugs is a personal decision that should be made based on informed discussions with healthcare providers and thorough research into the options available.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
America's Most Talked-About Drug Has A Surprising Secret: 69% of GLP-1 Users Are Unlikely To Admit Taking It
While GLP-1 medications have become one of the most visible health trends in America, a report found that less than a third (31%) of current and former GLP-1 users are likely to admit to using one.
-
Ozempic-Mounjaro Paved The Way: 3 New Drugs Likely To Enter Weight Loss Market
Ozempic and Mounjaro are popular weight loss medications that were developed for blood sugar control in individuals with diabetes. Here are the 3 new drugs that are likely to enter the weight loss market as oral GLP-1 drugs.
-
AstraZeneca's Oral GLP-1 Drug Elecoglipron Drives Up To 11.8% Weight Loss In Trial
The positive results come from the Phase 2 VISTA clinical trial, which evaluated elecoglipron in adults with obesity or overweight who also had at least one weight-related health condition.
-
Big Bang Theory's Mayim Bialik's GLP-1 Drug Experience Was A "Nightmare": What Happened
Bialik explained that she did not start taking a GLP-1 drug simply to lose weight. Instead, she hoped it might help with health issues that had affected her for years.
-
Weight Loss Drugs Reduce The Risk Of Breast Cancer By 30%, Finds New Study
Researchers examined health records to compare women who used GLP-1 medications with those who did not. The results showed that women taking these drugs were about 30% less likely to develop breast cancer than women who were not using them.
-
Harvard-Trained Gastroenterologist Reveals What Most People Miss About GLP-1 Drugs
Strap: A Harvard- and Stanford-trained gastroenterologist shares some key facts on GLP-1 drugs that most people often ignore.
-
Ozempic And Wegovy Weight Loss Eventually Plateaus, Study Explains Why
While semaglutide has shown impressive results in aiding weight loss, many users may experience a plateau after an initial period of significant weight loss.
-
Popular Weight Loss Drug Wegovy Linked To Rare Blinding Eye Condition, Finds Study
The study does not say that Wegovy directly causes blindness. Instead, researchers found a strong link between the drug and a condition called ischemic optic neuropathy.
-
Weight Loss Drugs May Impact Brain's Reward Centre, Study Warns
Newer oral weight loss drugs could be doing more than only suppressing appetite -- they may also be directly altering brain circuits that control motivation and reward, according to a new study.
-
Dr Reddy's Wins Nod to Sell Generic Ozempic, Check Cost Of Weight-Loss Drug
The entry of Dr Reddy's generic is triggering a price battle among pharmaceutical companies worldwide.
-
Fake Weight Loss Drug Racket Busted In Gurugram, 2 Arrested
Authorities arrest two in Gurugram for making and selling fake Mounjaro injections.
